Using data from a randomized phase III clinical trial of neuroblastoma patients (treated with or without immunotherapy) performed by the...

Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in...

Researchers have newly identified a universal, essential biomarker for the childhood cancer neuroblastoma – and a potential new target...

New NCCN Guidelines for Neuroblastoma address the importance and impact of risk stratification for treating one of the more common types...

A UCF cancer researcher is discovering ways that the body's own natural killer (NK) cells can be energized to fight deadly pediatric...

Liquid biopsies are a promise for the future of personalized cancer medicine: Many children with high-risk neuroblastoma, i.e. 50 percent...

A new treatment for a rare form of children’s cancer – which combines anti-tumour drugs with chemotherapy – improves the chances of...

Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could...

A detailed 'atlas' of neuroblastoma tumors points to a new target for immunotherapy. Scientists from the Princess Máxima Center for...

The drug, called eflornithine (DFMO) and newly branded as IWILFIN by US WorldMeds, reduces the risk of relapse for pediatric high-risk...